Bill Text: TX SB2009 | 2021-2022 | 87th Legislature | Introduced
Bill Title: Relating to the designation of centers of excellence for the management and treatment of placenta accreta spectrum disorder.
Sponsorship: Partisan Bill (Republican 1)
Status: (Introduced - Dead) 2021-04-01 - Referred to Health & Human Services [SB2009 Detail]
Download: Texas-2021-SB2009-Introduced.html
| 87R5114 SRA-D | ||
| By: Buckingham | S.B. No. 2009 | |
|
|
||
|
|
||
| relating to the designation of centers of excellence for the | ||
| management and treatment of placenta accreta spectrum disorder. | ||
| BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS: | ||
| SECTION 1. Chapter 32, Health and Safety Code, is amended by | ||
| adding Subchapter G to read as follows: | ||
| SUBCHAPTER G. CENTERS OF EXCELLENCE FOR MANAGEMENT AND TREATMENT | ||
| OF PLACENTA ACCRETA SPECTRUM DISORDER | ||
| Sec. 32.201. DEFINITION. In this subchapter, "placenta | ||
| accreta spectrum disorder" includes placenta accreta, placenta | ||
| increta, and placenta percreta. | ||
| Sec. 32.202. DESIGNATION OF CENTERS OF EXCELLENCE. (a) The | ||
| department, in consultation with the Texas Maternal Mortality and | ||
| Morbidity Review Committee established under Chapter 34, shall | ||
| designate as centers of excellence for the management and treatment | ||
| of placenta accreta spectrum disorder one or more health care | ||
| entities or programs in this state, including any institution or | ||
| community hospital with the appropriate resources and personnel, as | ||
| determined by the department and the review committee. | ||
| (b) The executive commissioner, in consultation with the | ||
| department and the Texas Maternal Mortality and Morbidity Review | ||
| Committee, shall adopt rules necessary for a health care entity or | ||
| program in this state to be designated as a center of excellence for | ||
| management and treatment of placenta accreta spectrum disorder. | ||
| Sec. 32.203. SUBCOMMITTEE. (a) The department, in | ||
| consultation with the Texas Maternal Mortality and Morbidity Review | ||
| Committee, shall appoint a subcommittee of the review committee to | ||
| advise the executive commissioner on the adoption of rules under | ||
| Section 32.202. As part of the subcommittee's duties under this | ||
| subsection, the subcommittee specifically shall advise the | ||
| executive commissioner on the criteria necessary for a health care | ||
| entity or program in this state to be awarded a designation under | ||
| this subchapter. | ||
| (b) The subcommittee must consist of individuals with | ||
| expertise in the management and treatment of placenta accreta | ||
| spectrum disorder. A majority of the members of the subcommittee | ||
| must practice in those areas in a health profession in this state. | ||
| The subcommittee may include national and international experts. | ||
| Sec. 32.204. PRIORITY CONSIDERATIONS FOR CENTER | ||
| DESIGNATIONS. The rules adopted under Section 32.202 must | ||
| prioritize awarding a designation under this subchapter to a health | ||
| care entity or program that: | ||
| (1) offers specialized management services for | ||
| placenta accreta spectrum disorder through a multi-specialty | ||
| clinical program and an associated hospital that provides advanced | ||
| neonatal and maternal care in accordance with the hospital's level | ||
| of care designation assigned under Section 241.182; | ||
| (2) demonstrates a significant commitment to research | ||
| in and advancing the field of care for placenta accreta spectrum | ||
| disorder; | ||
| (3) fosters telemedicine, referral, and transport | ||
| relationships with rural hospitals in this state; and | ||
| (4) integrates an advanced placenta accreta spectrum | ||
| disorder management program with a program that provides | ||
| appropriate long-term monitoring and follow-up care for patients. | ||
| Sec. 32.205. REQUIREMENTS FOR CENTER DESIGNATION. The | ||
| rules adopted under Section 32.202 must ensure that a health care | ||
| entity or program in this state that receives a center of excellence | ||
| designation under this subchapter: | ||
| (1) provides or is affiliated with a hospital that | ||
| provides advanced neonatal and maternal care in accordance with the | ||
| hospital's level of care designation assigned under Section | ||
| 241.182; | ||
| (2) establishes minimum criteria for medical, | ||
| nursing, ancillary, and support staff, in addition to any other | ||
| criteria required under Section 32.202; | ||
| (3) measures short-term and long-term patient | ||
| diagnostic and therapeutic outcomes; and | ||
| (4) submits to the department annual reports | ||
| containing aggregate data on short-term and long-term diagnostic | ||
| and therapeutic outcomes as requested or required by the department | ||
| and makes those reports available to the public on the entity's or | ||
| program's Internet website. | ||
| SECTION 2. (a) Not later than December 1, 2021, the | ||
| Department of State Health Services, in consultation with the Texas | ||
| Maternal Mortality and Morbidity Review Committee established | ||
| under Chapter 34, Health and Safety Code, shall appoint members to | ||
| the subcommittee as required by Section 32.203, Health and Safety | ||
| Code, as added by this Act. | ||
| (b) Not later than September 1, 2022, the executive | ||
| commissioner of the Health and Human Services Commission shall | ||
| adopt rules as required by Section 32.202, Health and Safety Code, | ||
| as added by this Act. | ||
| (c) Not later than September 1, 2022, the Department of | ||
| State Health Services shall begin awarding designations of centers | ||
| of excellence as required by Subchapter G, Chapter 32, Health and | ||
| Safety Code, as added by this Act. | ||
| SECTION 3. This Act takes effect September 1, 2021. | ||
